Otonomy Lands $10,000,000 Series A Funding

  • Feed Type
  • Date
    6/11/2010
  • Company Name
    Otonomy
  • Mailing Address
    5626 Oberlin Dr. San Diego, CA 92121
  • Company Description
    Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. This field represents a large opportunity as there are no approved drug treatments for the nearly 30 million Americans facing debilitating hearing and balance disorders such as Ménière’s disease, sudden sensorineural hearing loss, noise-induced hearing loss, age-related hearing impairment, and tinnitus.
  • Website
    http://www.otonomy.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to support the ongoing clinical trial for OTO-104 in Meniere’s disease, initiate IND-enabling studies for OTO-203, and continue early-stage development of a third program.
  • M&A Terms
  • Venture Investor
    Avalon Ventures

By posting a comment, you agree to our terms and conditions.